Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

This week saw the release of the first batches of the new H1N1 vaccine, and with it came the usual fears that there won’t be enough treatments to go around, or that the vaccine will cause more harm than good. First out the gate is the nasal version of the vaccine, which is being distributed to healthcare workers and infants this week. The traditional injectible vaccine will follow with a million doses being delivered every week starting in late October.

Today in Marketing/Media/ROI...keeping you current

Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09

Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address